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Objective: To investigate the chemical composition of a moderately polar extract
(CHCl3 soluble part of the MeOH–H2O extract) obtained from the aerial parts (leaves and
ﬂowers) of Centaurea diluta Ait. subsp. algeriensis (Coss. & Dur.) Maire, a species
endemic to Algeria and Morocco on which no reports are available to date. To evaluate
in vitro the cytotoxic, antifungal and antimicrobial activities of this extract and the
cytotoxic and antimicrobial activities of its isolated secondary metabolites.
Methods: The cytotoxic effects of the extract were investigated on 3 human cancer cell
lines i.e. the A549 non-small-cell lung carcinoma (NSCLC), the MCF7 breast adeno-
carcinoma and the U373 glioblastoma using a MTT colorimetric assay. Biological data
allowed to guide the fractionation of the extract by separation and puriﬁcation on silica
gel 60 (CC and TLC). The isolated compounds which were characterized by spectral
analysis, mainly HR-ESIMS, HR-EIMS, UV and NMR experiments (1H, 13C, COSY,
ROESY, HSQC and HMBC) and comparison of their spectroscopic data with those re-
ported in the literature, were evaluated for cytotoxic activities on six cancer cell lines
(A549, MCF7, U373, Hs683 human glioma, PC3 human prostate and B16-F10 murine
melanoma). The direct and indirect antibacterial and antifungal activities were determined
using microdilution methods for the raw extract and TLC-bioautography and micro-
dilution methods against standard and clinical strains for the isolated compounds.
Results: The raw extract reduced cell viability with IC50s of 27, 25 and 21 mg/mL on
A549, MCF7 and U373, respectively. Five secondary metabolites: two phenolic com-
pounds (vanillin 1, paridol 3), a lignan [(−)-arctigenin 2] and two ﬂavonoid aglycones
(eupatilin 4 and jaceosidin 5), were then isolated from this extract. Moderate cytotoxic
effects were observed for (−)-arctigenin 2 (IC50s: 28 and 33 mM on Hs683 and B16-F10,
respectively), eupatilin 4 (IC50s: 33 and 47 mM on B16-F10 and PC3, respectively) and
jaceosidin 5 (IC50s: 32 and 40 mM on PC3 and B16-F10, respectively).
Conclusions: All the isolated compounds were described for the ﬁrst time from this
species. Although inactive against 7 tested microorganisms (fungi, bacteria and yeast,
human or plant pathogens), the raw extract was able to potentiate the effect of beta-lactamrticle under the CC BY-NC-ND license (http://
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inhibitory concentrations (MICs) by a factor of 2-32-fold. No synergy was found between
the extract and streptomycin. From the ﬁve isolated compounds only jaseosidin 5 showed
a moderate antimicrobial activity.1. Introduction
The genusCentaurea (tribeCynareae, familyAsteraceae) is one
of the most widely distributed plant genera in the world.Centaurea
includesmore than 500 species, 45 ofwhich grow spontaneously in
Algeria, with 7 species localized in the Sahara [1,2]. Although, to
our best knowledge, no traditional uses or pharmacological
studies are reported so far for the species Centaurea diluta
(C. diluta), many other Centaurea species are well known in
traditherapy. For example, in Turkey, dried ﬂowers of Centaurea
cyanus are used in infusion to relieve diarrhea, gain energy,
increase appetite, and to relieve chest tightness; Centaurea
calcitrapa is used (infusion) as a febrifuge; Centaurea jacea is
used to reduce fever, to start menstruation, to relieve constipation
and increase appetite [3,4]. In Tunisia, Centaurea furfuracea, an
endemic species from the desert regions of the North of Africa
[5], is used as astringent and diuretic [6], while, in Algeria, the
roots of Centaurea incana are used in the area of Aure`s for the
treatment of liver diseases [7] and Centaurea pullata is used in
the preparation of a local traditional dish called “El Hammama”
[8]. Various studies have shown medicinal properties of
Centaurea species, mainly as analgesic [9], cytotoxic [10],
antibacterial [11] and antifungal [12].
Centaurea typically present high structural diversity in major
bioactive compounds, including triterpenes, ﬂavonoids, lignans
and sesquiterpene lactones [13–21]. In specimens of C. diluta,
cultivated in the botanical garden of Technical University of
Braunschweig, Germany, polyacetylenic compounds have been
reported [22–24]. In the essential oil of C. diluta Aiton aerial
parts, collected from Sicily, Italy [25], the most abundant
compounds were fatty acids and derivatives, notably
hexadecanoic acid (21.3%) and (Z,Z)-9,12-octadecadienoic
acid methyl ester (12.2%), followed by hydrocarbons (15.3%),
terpenoids being present in low amounts (2.8%).
Given the interest of Centaurea pharmacology and phyto-
chemistry, the present paper concentrates on a relatively un-
known subspecies, C. diluta Ait. subsp. algeriensis (Coss. &
Durieu) Maire [26], endemic to Algeria and Morocco [2].
2. Material and methods
2.1. Chemicals, reagents and general
Solvents were analytical grade. Trypsin 0.5% in EDTA,
RPMI1640 red phenol and fetal bovine serum (FBS) were pur-
chased from Gibco® Invitrogen (Merelbeke, Belgium). 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT)
was obtained from Sigma Aldrich® (Bornem, Belgium).
Dimethyl sulfoxide (DMSO) was obtained from Merck®
(Overijse, Belgium). RNAse-free water was from Braun®
(Machelen, Belgium). The Penicillin V was purchased fromCerta SA ACA Pharma NV, the ampicillin, amoxicillin and
oxacillin were purchased from Sigma–Aldrich.
The absorbance of the reaction mixture of MTT test was
measured by spectrophotometer microplate reader Model
680XR, Bio-Rad®, Nazareth Eke (Belgium). The cells were
counted by Cells Culture Counter, Beckman (Analis®, Suarle´e,
Belgium). The following apparatus were also used: optical mi-
croscope PCM-type Axiovert S100 (Zeiss, Nederlands) and
laminar ﬂow hood class II (IKS®, Leerdam, Nederlands).
Melting points were determined on a SMP10 Bu¨chi B-540
Stuart Biocote apparatus and are uncorrected. Plant material
powdering: Mill: Culatti, CZ13 model, Reference DCFH48.
TLC: pre-coated aluminum foil silica gel 60 F254 & TLC silica
gel 60 F254 Plastic roll 500 × 20 cm (Merck KGaA, Germany),
visualized using UV lamp (CAMAG 254 nm & 366 nm) and by
detection with a spraying reagent (vanillin-sulfuric at 10% and/
or anisaldehyde) followed by heating at 100 C for 3–5 min.
Column chromatography (CC): silica gel 60 (Merck KGaA,
Germany, 230–400 mesh ASTM). Routine preparative thin-
layer chromatography (PLC): silica gel plates (20 × 20 cm Sil-
ica gel 60 PF254, Merck), Optical rotation: Perkin–Elmer 241
polarimeter at lNa 589 nm.
UV spectra were recorded using a Thermo Electron Corpo-
ration evolution 300 spectrophotometer. 1H NMR and 13C NMR
spectra were recorded on Bruker Avance 300, 400 MHz and
Varian 600 MHz; 2D-NMR experiments (COSY, HSQC,
HMBC, NOESY and ROESY) were performed on Bruker
Avance 400 MHz or Varian 600 MHz spectrometers. Spectra of
compounds 1, 2 and 3 were recorded in CDCl3, compound 4 in
DMSO-d6 and compound 5 in CD3OD. A Shigemi tube was
used for compound 2.
High resolution mass spectra in positive mode were recorded
by direct infusion using a 6520 series quadrupole time-of-ﬂight
(Q-TOF) mass spectrometer (Agilent, Palo Alto, CA, USA)
ﬁtted with an electrospray ionization (ESI) source in positive
mode. The error between the observed and calculated masses is
expressed in ppm; below 5 ppm, the compounds were consid-
ered to correspond to predicted formula.2.2. Plant material
The aerial parts of C. diluta Ait. subsp. algeriensis (Coss. &
Dur.) were collected in the ﬂowering stage in the area of Djelfa
(1038 m, 34 530 39.600 N, 3 30 56.300 E) in June 2012. The plant
was authenticated by Professor Mohamed Kaabache, specialist
in the identiﬁcation of Algerian Centaurea species (Ferhat
Abbas University, Setif, Algeria). A voucher specimen has been
deposited in the National Herbarium of Belgium (National
Botanical Garden of Meise) under the number
BR0000013666187.
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Air-dried aerial parts (leaves and ﬂowers, 1.5 kg) of C. diluta
Ait. subsp. algeriensis (Coss. & Dur.) were powdered (slight
grinding with controlled temperature, up to 35 C) and
macerated at room temperature with MeOH–H2O (77:23, v/v)
(25 L) for 48 h, four times. The ﬁltrates were combined,
concentrated under reduced pressure, diluted in H2O (600 mL)
under magnetic stirring and maintained at 4 C for one night to
precipitate a maximum of chlorophylls. After ﬁltration, the
resulting solution was successively extracted with solvents with
increasing polarities (petroleum ether, chloroform, ethyl acetate
and n-butanol) [27,28]. The present study focused on the
chloroform soluble part which was dried with anhydrous
Na2SO4, ﬁltered and concentrated under vacuum at room
temperature to yield the CHCl3 extract (4.0 g, yield: 0.27%,
w/w). The chloroform extract was fractionated by column
chromatography (120 g of silica gel; CH2Cl2/EtOAc/MeOH
step gradients) to yield 23 fractions (F1–F23), combined
according to their TLC proﬁles.
Fraction F3 (26.2 mg) (CH2Cl2/EtOAc 98:2) was subjected to
preparative TLC on silica gel; eluting with petroleum ether/
EtOAc/acetone (6:3:1) yielded vanillin 1 as white crystals
(3.5 mg) [29,30].
Fractions F4 (12.2 mg) (CH2Cl2/EtOAc 98:2), F5 (13.0 mg)
(CH2Cl2/EtOAc 98:2) and F6 (28.5 mg) (CH2Cl2/EtOAc 95:5)
were combined and rechromatographed by CC (600 mg of silica
gel; cyclohexane/EtOAc/acetone step gradients) to yield 21
subfractions (F01–F021) according to TLC proﬁles. Subtraction
F03 (cyclohexane/EtOAc/acetone 6:6:2) yielded (−)-arctigenin 2
(3.2 mg) [17,31] and subtraction F04 (cyclohexane/EtOAc/acetone
5:2.5:2.5) gave paridol 3 (4.5 mg) [32,33].
Fraction F8 (CH2Cl2/EtOAc 95:5) (44.4 mg) yielded up on
concentration a yellowish compound which was washed with
MeOH to obtain eupatilin 4 (7.5 mg) as needles [11,34]. Fraction
F10 (CH2Cl2/EtOAc 87.5:12.5) (19.60 mg) was
chromatographed on preparative plates of silica gel eluted with
CH2Cl2/EtOAc (4:1) to give jaceosidin 5 as a yellowish
powder (5.0 mg) [35,36].
2.4. Cell cultures
The human cancer cell lines included the A549 (Deutsche
Sammlung von Mikroorganismen und Zellkulturen, DSMZ code
ACC107), NSCLC carcinoma, the U373 (European Collection
of Cell Culture, ECACC 08061901) glioblastoma, the PC3
prostate carcinoma (DSMZ code ACC465), the Hs683 glioma
(American Type Culture Collection, ATCC code HTB-138) and
the MCF7 (DSMZ code ACC115) breast adenocarcinoma. The
murine tumor cell line included the B16-F10 (American Type
Culture Collection ATCC code CRL-6475) melanoma.
2.4.1. Viability assay
The cytotoxic properties of the raw chloroform extract and
isolated compounds were assessed, using a 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
assay [37,38]. Brieﬂy, this test is based on the capability of living
cells to reduce the yellow MTT to a blue formazan compound, a
reaction mediated by the mitochondrial succinate
dehydrogenase. Cells were seeded (cells per well, A549:
1500; B16F10: 1000; Hs683: 1500; MCF7: 2800; PC3:3000; U373: 1800) and allowed to adhere for 24 h before
adding test compounds (100 mL; ﬁnal concentrations from
10−4 M to 10−8 M). In the same condition, for the chloroform
extract, cells were seeded (cells per well, A549: 1200;
MCF7: 2500; U373: 1800; 100 mL; ﬁnal concentrations from
100 mg/mL to 10−2 mg/mL). The cells in medium alone
without drug were considered as a negative control. After
72 h contact, the culture medium was replaced by a 0.5 mg/
mL MTT solution in RPMI medium without phenol red
(100 mL/well). After 3 h incubation, the formazan crystals
were centrifuged and dissolved in 100 mL/well of DMSO.
The absorbance of each well was then measured at 570 nm
and 690 nm (reference) wavelength. The IC50 values were
calculated as follows:
IC50 = [(X2 − X1) × (50 − Y1)/(Y2 − Y1)] + X1, where.
X1 and X2: are the higher and lower concentrations that
border the concentration that reduces the global cell growth by
the value closest to 50%.
Y1 and Y2: are the mean percentages of viable cells at the X1
and X2 concentrations.
2.5. Antimicrobial and antifungal assays
2.5.1. Microorganisms
The microorganisms used in the antimicrobial tests were: (1)
Gram-positive bacteria: Staphylococcus aureus ATCC 6538
(S. aureus ATCC 6538), Staphylococcus aureus C98506
(S. aureus C98506), Staphylococcus aureus C100459 (S. aureus
C100459) and Staphylococcus aureus ATCC 33591 (S. aureus
ATCC 33591); (2) Gram-negative bacteria: Escherichia coli
ATCC 25922 (E. coli ATCC 25922) and a plant pathogen:
Pseudomonas syringae DC 3000; (3) plant pathogen fungi:
Fusarium oxysporum, Fusarium oxysporum sporulent, Clado-
sporium cucumerinum, Botrytis cinerea, Colletotrichum lage-
narium and Pythium aphanidermatum; and (4) a plant pathogen
yeast: Rhodotorula aurantiaca. The ATCC strains were ob-
tained from the American Type Culture Collection; strains
C98506 and C100459 were clinical isolates, a generous gift
from the Centre Hospitalier Universitaire of Charleroi, Belgium
(Mr. Lerson). Strains C98506, C100459 and ATCC 33591 are
methicillin-resistant Staphylococcus aureus (MRSA). The
different plant pathogens were provided by the Centre Wallon de
Biologie Industrielle, Bio-Industrie Unite´ Gembloux Agro-Bio
Tech, Universite´ de Lie`ge, 5030 Gembloux, Belgique (Dr.
Ongena).
2.5.2. Direct and indirect antimicrobial effects
Direct and indirect antibacterial effects were evaluated by a
broth microdilution method [39].
The raw extract and isolated compounds, dissolved in
DMSO, were further diluted in Mueller Hinton broth (MHB),
the ﬁnal DMSO concentration being maximum 4%. These so-
lutions were transferred into 96-wells plates and serially diluted
using MHB. The bacterial inoculum prepared from an overnight
culture, diluted in 0.85% NaCl to achieve 0.5 Mc Farland
(108 cells/mL), was further diluted 1/100 to be inoculated in the
96-wells plates (100 mL/well). The plates were incubated at
37 C for 24 h, added with an aqueous solution of MTT (0.8 mg/
mL) and reincubated for 4 h. The minimum inhibitory
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completely inhibited the growth of microorganisms, detected by
unaided eyes using the MTT staining.
2.5.3. Direct and indirect antibacterial bioautography
TLC was performed for the extract and the puriﬁed com-
pounds on precoated silica gel 60 F254 glass plates (Merck,
Darmstadt, Germany). Plates were thoroughly dried at room
temperature. One mL of 0.5 Mc Farland microorganism sus-
pension was added to 9 mL MH agar (107 CFU/mL) at 37 C
and poured on the TLC plates. After solidiﬁcation, the plates
were incubated overnight at 37 C. The bioautography was
subsequently visualized by spraying MTT (0.8 mg/mL) fol-
lowed by an additional incubation at 37 C for 4 h [40].
To study indirect antibacterial activity against MRSA, a sub-
inhibitory concentration of penicillin V (1 mg/mL) was incor-
porated in the mixture of MHB and agar; products with no direct
antibacterial activity were selected, chromatographed, and bio-
autographed with this medium as described above.
3. Results
3.1. Structural elucidation of compounds 1–5
The structures of the isolated compounds were established by
spectral analysis, mainly UV–Vis, HRESI-MS, 1H-, 13C-, and
2D-NMR (COSY, ROESY, HSQC and HMBC) as well as by
comparing their spectroscopic data with those reported in the
literature.
Vanillin 1: White crystals; MP = 82 C; UV (MeOH)
lmax(nm): 230, 279, 309; HRESI-QTOF-MS (positive mode) m/
z: 153.0545 [M+H]+ (calculated for C8H9O3: 153.0546),
175.0372 [M+Na]+ (calculated for C8H8O3Na: 175.0366),
191.0216 [M+K]+ (calculated for C8H8O3K: 191.0105),
measured exact mass: 152.0471 (calculated for C8H8O3:
152.0473), molecular formula C8H8O3;
1H NMR (300 MHz,
CDCl3) d (ppm, J/Hz): 9.83 (1H, s, H-7), 7.44 (1H, d,
J = 1.8 Hz, H-2), 7.41 (1H, dd, J = 9.0, 1.8 Hz, H-6), 7.03, (1H,
d, J = 9.0 Hz, H-5), 6.62 (1H, brs, 4-OH), 3.98 (3H, s, OCH3-3);
13C NMR (75 MHz, CDCl3) d (ppm): 190.86 (C, C-7), 151.62
(C, C-4), 147.05 (C, C-3), 130.33 (C, C-1), 127.45 (CH, C-6),
114.04 (CH, C-5), 108.75 (CH, C-2), 56.40 (CH3, OCH3-3).
(−)-Arctigenin 2: White powder; MP = 103 C;
½a20D = − 17:27 (EtOH, c, 0.145); HRESI-QTOF-MS (positive
mode) m/z: 373.1655 [M+H]+ (calculated for C21H25O6:
373.1646), 395.1478 [M+Na]+ (calculated for C21H24O6Na:
395.1467), measured exact mass: 372.1569 (calculated for
C21H24O6: 372.1577). These data led to the molecular formula
C21H24O6; HRESI-QTOF-MS/MS: m/z:355.1556 [M+H–
H2O]
+ (C21H23O5) which conﬁrm the presence of a hydroxyl
group; 1H NMR (600 MHz, CDCl3) d (ppm, J/Hz): 6.80 (1H,
d, J = 7.9 Hz, H-50), 6.72 (1H, d, J = 8.1 Hz, H-5), 6.62 (1H, d,
J = 1.7 Hz, H-20), 6.59 (1H, dd, J = 7.9, 1.7 Hz, H-60), 6.53
(1H, dd, J = 8.1, 1.7 Hz, H-6), 6.44 (1H, d, J = 1.7 Hz, H-2),
5.50 (1H, brs, 40-OH), 4.12 (1H, dd, J = 9.0, 7.4 Hz, H-9a),
3.87 (1H, dd, J = 9.0, 7.6 Hz, H-9b), 3.83 (3H, s, OCH3-30),
3.80 (3H, s, OCH3-4), 3.79 (3H, s, OCH3-3), 2.92 (1H, dd,
J = 14.1, 5.3 Hz, H-70a), 2.89 (1H, dd, J = 14.1, 7.1 Hz, H-70b),
2.61(1H, dd, J = 14.7, 7.4 Hz, H-7a), 2.54 (1H, m, H-80), 2.52
(1H, m*, H-7b), 2.47 (1H, m, H-8), *: partially overlapped by
the signal of H-80; 13C NMR (150 MHz, CDCl3) d (ppm):178.96 (C, C-90), 149.24 (C, C-3), 148.05 (C, C-30), 146.91 (C,
C-4), 144.76 (C, C-40), 130.65 (C, C-1), 129.72 (C, C-10),
122.32 (CH, C-60), 120.80 (CH, C-6), 114.31 (CH, C-50),
111.97 (CH, C-20), 111.71 (CH, C-2), 111.48 (CH, C-5), 71.53
(CH2, C-9), 56.12 (CH3, OCH3-4), 56.07 (CH3, OCH3-30),
56.02 (CH3, OCH3-3), 46.82 (CH, C-80), 41.14 (CH, C-8),
38.42 (CH2, C-7), 34.74 (CH2, C-70). Our results which were
conﬁrmed by the analysis of the ROESY spectrum experiment
complete the spectroscopic data previously reported for this
molecule [31,41].
Paridol 3: White powder; MP = 128 C; HRESI-QTOF-MS
(positive mode) m/z: 153.0544 [M+H]+ (calculated for
C8H9O3: 153.0546), 175.0369 [M+Na]
+ (calculated for
C8H8O3Na: 175.0369), 343.0543 [2M+K]
+ (calculated for
C16H16O6K: 343.0546), measured exact mass: 152.0472,
(calculated for C8H8O3: 152.0473), molecular formula C8H8O3.
HRESI-QTOF-MS/MS of [M+H]+: 153.0547 [M+H]+,
135.0239 [M+H–H2O]
+, 121.0289 [M+H–CH3OH]
+, these two
last ions conﬁrmed the presence of the hydroxyl and methoxyl
groups in the molecule; 1H NMR (300 MHz, CDCl3) d (ppm, J/
Hz): 7.95 (2H, d, J = 8.9 Hz, H-2 & H-6), 6.86 (2H, d,
J = 8.9 Hz, H-3 & H-5), 5.98 (1H, brs, 4-OH), 3.88 (3H, s,
OCH3-7);
13C NMR (75 MHz, CDCl3) d 167.08 (C, C-7),
159.90 (C, C-4), 132.06 (CH, C-2 & C-6), 122.93 (C, C-1),
115.33 (CH, C-3 & C-5), 52.08 (CH3, OCH3-7).
Eupatilin 4: Yellow crystals; MP = 236 C; UV (MeOH)
lmax(nm): 276, 340; +NaOH: 276, 320, 360 (with hypochro-
mic effect); +AlCl3: 282, 368; +AlCl3 + HCl: 283,
361; +NaOAc: 276, 366; +NaOAc + H3BO3: 276, 357;
HRESI-QTOF-MS (positive mode) m/z: 345.0968 [M+H]+
(calculated for C18H17O7: 345.0969), 367.0788 [M+Na]
+
(calculated for C18H16O7Na: 367.0788), 383.0537
[M+K]+(calculated for C18H16O7 K: 383.0528), 689.1736
[2M+H]+ (calculated for C36H33O14: 689.1865), 712.1717
[2M+Na]+ (calculated for C36H32O14Na: 712.1718), 727.1077
[2M+K]+ (calculated for C36H32O14 K: 712.1424), measured
exact mass: 344.0888 (calculated for C18H16O7: 344.0896),
molecular formula C18H16O7;
1H NMR (400 MHz, DMSO-d6)
d (ppm, J/Hz): 13.04 (1H, s, OH-5), 7.68 (1H, dd, J = 8.5,
2.0 Hz, H-60), 7.56 (1H, d, J = 2.0 Hz, H-20), 7.13 (1H, d,
J = 8.5 Hz, H-50), 6.97 (1H, s, H-3), 6.64, (1H, s, H-8),
3.88(3H, s, 30-OCH3), 3.85, (3H, s, 40-OCH3) 3.75, (3H, s, 6-
OCH3);
13C NMR (100 MHz, DMSO-d6); d (ppm): 182.01 (C,
C-4), 163.26 (C, C-2), 157.12 (C, C-7), 152.83 (C, C-5),
151.96 (C, C-9), 149.06 (C, C-40), 148.84 (C, C-30), 131.11 (C,
C-6), 122.83 (C, C-10), 120.10 (CH, C-60), 111.55 (CH, C-50),
109.26 (CH, C-20), 104.22 (C, C-10), 103.36 (CH, C-3), 94.33
(CH, C-8), 59.97 (CH3, OCH3-6), 55.88 (CH3, OCH3-40),
55.76 (CH3, OCH3-30).
Jaceosidin 5: Yellowish powder; MP = 237 C, UV (MeOH)
lmax: 276, 346; +NaOH: 276, 314, 360 (with hyperchromic
effect); +AlCl3: 282, 368; +AlCl3 + HCl: 283, 361; +NaOAc:
278, 366; +NaOAc + H3BO3: 276, 357; HRESI-QTOF-MS
(positive mode) m/z: 331.0811 (calculated for C17H15O7:
331.0812), 353.0625 [M+Na]+ (calculated for C17H14O7Na:
353.0632), 661.1542 [2M+H]+ (calculated for C34H29O14:
661.1552), 683.1485 [2M+Na]+ (calculated for C34H28O14Na:
683.1371), 701.0942 [2M+K]+ (calculated for C34H28O14K:
701.1137), 991.2454 [3M+H]+(calculated for C51H43O21:
991.2291), measured exact mass: 330.0744, (calculated for
C17H14O7: 330.0740), molecular formula C17H14O7;
1H NMR
Hane`ne Zater et al./Asian Paciﬁc Journal of Tropical Medicine 2016; 9(6): 554–561558(400 MHz, CH3OH-d4) d (ppm, J/Hz): 7.52 (1H, dd, J = 8.5,
2.0 Hz, H-60), 7.50 (1H, d, J = 1.9 Hz, H-20), 7.48 (1H, d,
J = 8.5 Hz, H-50), 6.94 (1H, s, H-8), 6.64 (1H, s, H-3), 3.96
(3H, s, OCH3-30), 3.88 (3H, s, OCH3-6).
13C NMR (75 MHz,
CH3OH-d4) d (ppm): 184.21 (C, C-4), 166.36 (C, C-2), 158.92
(C, C-7), 154.83 (C, C-5), 154.70 (C, C-9), 151.70 (C, C-40),
149.44 (C, C-30), 132.92 (C, C-6), 123.90 (C, C-10), 121.64 (C,
C-60), 116.91 (CH, C-50), 110.34 (CH, C-20), 105.58 (C, C-10),
103.59 (CH, C-3), 95.65 (CH, C-8), 61.04 (CH3, OCH3-6),
56.50 (CH3, OCH3-30).
3.2. Biological activities
3.2.1. Cytotoxic effects
The CHCl3 extract showed cell growth inhibitory activity
against all 3 tested cell lines in the mg/mL range (Figure 1).
These results are in agreement with previous data from an
Algerian Centaurea species; the raw chloroformic extract of
Centaurea musimomum (musimonum) Maire showed on KB
cells, cytotoxic activity with growth inhibition of 89% at 10 mg/
mL and 26% at 1 mg/mL [10].
The evaluation of the isolated compounds 1 to 5 indicated
moderate growth inhibitory/cytotoxic activities for eupatilin 4Figure 1. Cytotoxic effects (IC50) of the chloroform extract and the isolated c(33–85 mM), jaceosidin 5 (32–49 mM), and (−)-arctigenin 2 (28–
82 mM) (Figure 1).
Our results showed that the chloroformic extract displayed
more signiﬁcant cytotoxic effects on cancer cells A549, MCF7
and U373 than the isolated pure compounds. This could be
attributed to the synergetic interactions, more especially as this
extract contains ﬂavonoids for which it is thought that they may
have a role to play in increasing the biological activity of other
compounds by synergistic or other mechanisms [42].
3.2.2. Antifungal and antimicrobial activities
Although inactive against 7 tested microorganisms (fungi,
bacteria and yeast, human or plant pathogens, Table 1), the raw
extract was able to potentiate the effect of beta-lactam antibiotics
on methicillin-resistant S. aureus (MRSA), reducing the minimal
inhibitory concentrations (MICs) by a factor of 2-32-fold
(Table 2). In a direct antibacterial TLC-bioautography assay,
compound 5 (jaceosidin), showed the highest activity (Tables 3
and 4). This was further investigated in a direct antibacterial
assay, but the activity was relatively quite low on Gram positive
and negative bacteria (MIC of 200 mg/mL on MRSA C98506,
MRSA C100459, MRSA ATCC 33591, MSSA ATCC 6538,
E. coli ATCC 25922).ompounds on different tumor cell lines.
Table 1
MIC of the chloroform extract (mg/mL).
Microorganisms tested MIC mg/mL
Staphylococcus aureus ATCC 6538 Gram+ 2000
Escherichia coli ATCC 25922 Gram− 2000
Pseudomonas syringae DC 3000 Gram− a
Fusarium oxysporum Fungus a
Fusarium oxysporum sporulent Fungus a
Cladosporium cucumerinum Fungus a
Botrytis cinerea Fungus a
Colletotricum lagenarium Fungus a
Rhodotorula aurantiaca Fungus a
a No effect at 250 mg/mL, the highest concentration tested for plant
pathogens.
Table 3
Antibacterial activity of the puriﬁed compounds (1–5) measured by a direct.
Compounds Inhibition zone in mm MRSA C9
Test 1 Te
Vanillin 1 4
(−)-Arctigenin 2 1.5
Paridol 3 2
Eupatilin 4 5
Jaceosidin 5 19 1
Table 4
Antibacterial activity of eupatilin 4 and jaceosidin 5, measured by a direct. T
Compounds Inhibition zone in mm MRSA
Test 1 T
Eupatilin 4 (15 mg) 7
Eupatilin 4 (25 mg) 6
Eupatilin 4 (50 mg) 8
Jaceosidin 5 (15 mg) 15
Jaceosidin 5 (25 mg) 15
Jaceosidin 5 (50 mg) >21
Table 2
Impact of the chloroform extract (200 mg/mL) on the susceptibility of the
MRSA towards various beta-lactam antibiotics.
Tested mixture MIC of the antibiotic (mg/mL)
MRSA
C98506
MRSA
C100459
Penicillin V alone
(with DMSO 4%)
16 8
Penicillin V + chloroform extract
(200 mg/mL)
8 2
Ampicillin alone
(with DMSO 4%)
16 4
Ampicillin + chloroform extract
(200 mg/mL)
8 4
Amoxicillin alone
(with DMSO 4%)
16 8
Amoxicillin + chloroform extract
(200 mg/mL)
4 8
Oxacillin alone
(with DMSO 4%)
16 4
Oxacillin + chloroform
extract (200 mg/mL)
0.5 2
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4.1. Phytochemical investigation
We report in this work the isolation, puriﬁcation and struc-
tural elucidation of chemical components of the chloroform
soluble part of the MeOH–H2O (77%) extract obtained from the
aerial parts (leaves and ﬂowers) of C. diluta Ait. subsp. alger-
iensis (Coss. & Durieu) Maire (Asteraceae). No report is avail-
able so far on the phytochemistry of this species endemic to
Algeria and Morocco. The present phytochemical investigation
allowed the isolation of a lignan [(−)-arctigenin], ﬂavonoids
(eupatilin and jaceosidin) and phenols (vanillin and paridol).
These results are in agreement with major studies reported on
different Centaurea species [14,43–48].
4.2. Biological activities
4.2.1. Cytotoxic effects
The raw extract and the isolated compounds were evaluated
for cytotoxic activity. Moderate cytotoxic effects were observed
for three compounds, (−)-arctigenin 2, eupatilin 4 and jaceosi-
din 5, with IC50s in the range 25–50 mg/mL. These data are in
agreement with previous studies. Indeed, arctigenin (unspeci-
ﬁed stereoisomer) as tumor speciﬁc agent that showed cyto-
toxicity to lung cancer (A549), liver cancer (HepG2) and
stomach cancer (KATO III) cells, but not cytotoxic to several
normal cell lines [49]. Arctigenin speciﬁcally inhibited the
proliferation of cancer cells, which might consequently lead
to the induction of apoptosis and is cytotoxic for human
hepatocellular carcinoma cell lines, the IC50 values after 12 h,
24 h and 48 h of treatment were respectively 38.29, 1.99 and
0.24 mM [50], the highest activity was demonstrated with IC50
values of 0.73 mM (HeLa), 3.47 mM (MCF7) and 4.47 mM
(A431) [46]. Eupatilin reduces aortic smooth muscle cell
proliferation and migration by inhibiting PI3K, MKK3/6, and
MKK4 activities (IC50, in Hec1A and KLE cells was 82.2
and 85.5 mM) [51,52] and jaceosidin can induce G2/M cellTLC-bioautography.
8546 Inhibition zone in mm MRSA C100459
st 2 Test 1 Test 2
4 0 0
1.5 0 0
2 0 0
5 6 6
9 21 21
LC-bioautography with different amounts spotted.
C98546 Inhibition zone in mm MRSA C100459
est 2 Test 1 Test 2
8 22 19
8 17 14
9 20 19
15 >21 >21
17 >21 >21
>21 >21 >21
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activation [53].
4.2.2. Antifungal and antimicrobial activities
The raw extract and the isolated secondary metabolites were
evaluated for antimicrobial activity. Although the raw extract
didn't show any antimicrobial effect on various bacteria or fungi,
it could potentiate the effect of beta-lactam antibiotics on
methicillin-resistant S. aureus (MRSA), reducing the minimal
inhibitory concentrations (MICs) by a factor of 2-32-fold.
Jaceosidin 5 showed a moderate antimicrobial activity (MIC of
200 mg/mL on MRSA C98506, MRSA C100459, MRSA ATCC
33591, MSSA ATCC 6538, E. coli ATCC 25922). This is in
agreement with previous results [54]. Jaceosidin 5 had the greatest
potency (MICs 16–32 mg/mL) against most S. aureus isolates [55].
The identiﬁcation of ﬁve compounds, vanillin, (−)-arctigenin,
paridol, eupatilin and jaceosidin, from the aerial parts (leaves
and ﬂowers) of C. diluta Ait. subsp. algeriensis (Coss. & Dur.)
M. (Asteraceae) emphasized the possible relevance of this plant
for Algerian traditional medicine and it is surprising that no
report has been published so far on eventual ethnomedical uses
of this species. This may be due to a low distribution of this
species or to an eventual toxicity that could have discouraged its
use in traditherapy; this warrants investigation. A promising
effect on bacterial resistance needs to be further investigated to
identify the compound(s) able to reverse bacterial beta-lactam
resistance.
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